Delivery of antisense oligonucleotides to nuclear telomere RNA by use of a complex between polysaccharide and polynucleotide

Bulletin of the Chemical Society of Japan

Volumn 80, Issue 6, 2007, Pages 1091-1098

  Minari, Jusaku ^a   Kubo, Takanori ^b   Ohba, Hideki ^b   Shimada, Naohiko ^a   Takeda, Yoich ^a   Karinaga, Ryouji ^a   Anada, Takahisa ^a   Koumoto, Kazuya ^a   Kawazu, Takeshi ^c   Nagasaki, Takeshi ^c   Shinkai, Seiji ^d   Sakurai, Kazuo ^a  

^a UNIVERSITY OF KITAKYUSHU   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c Osaka Prefecture University

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDES; ANTISENSE THERAPIES; CANCER THERAPIES; JURKAT CELLS; NATURAL POLYSACCHARIDES; NEOPLASTIC CELLS; NEW STRATEGIES; NUCLEAR TRANSPORTS; POLYNUCLEOTIDE; SCHIZOPHYLLAN; SIDE CHAINS; STREPTAVIDIN; TELOMERASE; TELOMERASE ACTIVITIES; TELOMERE;

NUCLEIC ACIDS; NUCLEOTIDES; OLIGONUCLEOTIDES; POLYSACCHARIDES; RNA;

MOLECULAR WEIGHT;

EID: 58149310777     PISSN: 00092673     EISSN: 13480634     Source Type: Journal    
DOI: 10.1246/bcsj.80.1091     Document Type: Article

References (41)

1. S. E. Hamilton, A. E. Pitts, R. R. Katipally, X. Jia, J. P. Rutter, B. A. Davies, J, W. Shay, W. E. Wright, D. R. Corey, Biochemistry 1997, 36, 11873.
2. A. N. Elayadi, D. A. Braasch, D. R. Corey, Biochemistry 2002, 41, 9973.
3. K. T. Flaherty, J. P. Stevenson, P. J. O'Dwyer, Curr. Opin. Oncol. 2001, 13, 499.
4. C. A. Stein, Biochim. Biophys. Acta 1999, 1489, 45.
5. T. V. Chirila, P. E. Rakoczy, K. L. Garrett, X. Lou, I. J. Constable, Biomaterials 2002, 23, 321.
6. C. A. Stein, Y. C. Cheng, Science 1993, 267, 1004.
7. S. L. Loke, C. A. Stein, X. H. Zhang, K. Mori, M. Nakanishi, C. Subasinghe, J. S. Cohen, L. M. Neckers, Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 3474.
8. C. A. Stein, A. M. Krieg, Applied Antisense Oligonucleotide Technology, Wiley-Liss, New York, 1998.
9. A. M. Krieg, C. A. Stein, Antisense Res. Dev. 1995, 5, 241.
10. B. Abdallah, L. Sachs, B. A. Demeneix, Biol. Cell 1995, 85, 1.
11. P. Lehn, S. Fabrega, N. Oudrhiri, J. Navarro, Adv. Drug Delivery Rev. 1998, 30, 5.
12. K. Sakurai, S. Shinkai, J. Am. Chem. Soc. 2000,122, 4520.
13. K. Sakurai, M. Mizu, S. Shinkai, Biomacromolecules 2001, 2, 641.
14. K. Miyoshi, K. Uezu, K. Sakurai, S. Shinkai, Chem. Biodiversity 2004, 1, 916.
15. M. Mizu, K. Koumoto, T. Anada, K. Sakurai, S. Shinkai, Biomaterials 2004, 25, 3117.
16. M. Mizu, K. Koumoto, T. Anada, R. Karinaga, T. Kimura, T. Nagasaki, S. Shinkai, K. Sakurai, Bull. Chem. Soc. Jpn. 2004, 77, 1101.
17. T. Matsumoto, M. Numata, T. Anada, M. Mizu, K. Koumoto, K. Sakurai, T. Nagasaki, S. Shinkai, Biochim. Biophys. Acta 2004, 1670, 91.
18. M. Mizu, K. Koumoto, T. Anada, T. Matsumoto, M. Numata, S. Shinkai, T. Nagasaki, K. Sakurai, J. Am. Chem. Soc. 2004, 126, 8372.
19. T. Kimura, K. Koumoto, M. Mizu, K. Sakurai, S. Shinkai, Chem. Lett. 2002, 1240.
20. K. Koumoto, T. Kimura, M. Mizu, K. Sakurai, S. Shinkai, Chem. Commun. 2001, 1962.
21. R. Karinaga, K. Koumoto, M. Mizu, T. Anada, S. Shinkai, K. Sakurai, Biomaterials 2005, 26, 4866.
22. T. Anada, R. Karinaga, K. Koumoto, M. Mizu, T. Nagasaki, Y. Kato, K. Taira, S. Shinkai, K. Sakurai, J. Controlled Release 2005, 108, 529.
23. T. Nagasaki, T. Kawazu, T. Tachibana, S. Tamagaki, S. Shinkai, J. Controlled Release 2005, 103, 199.
24. T. Kubo, Z. Zhelev, R. Bakalova, H. Ohba, K. Doi, M. Fujii, Org. Biomol. Chem. 2005, 3, 3257.
25. R. Bakalova, H. Ohba, Z. Zhelev, T. Kubo, M. Fujii, M. Ishikawa, Y. Shinohara, Y. Baba, Cancer Chemother. Pharmacol. 2004, 54, 161.
26. K. Koumoto, H. Kobayashi, M. Mizu, T. Kimura, K. Sakurai, T. Kunitake, S. Shinkai, Polym. J. 2004, 36, 380.
27. h, the particle consists of more than three SPG chains. The local structure of the particle should be triple helix of SPG or SPG/polynucleotide (A.-H. Bae, S.-W. Lee, M. Ikeda, M. Sano, S. Shinkai, K. Sakurai, Carbohydr. Res. 2004, 339, 251).
28. h. Of course, this is speculation, and experimental evidence is need.
29. N. Pante, M. Kann, Mol. Biol. Cell 2002, 13, 425.
30. M. P. Rout, G. Blobel, J. D. Aitchison, Cell 1997, 89, 715.
31. S. K. Vasu, D. J. Forbes, Curr. Opin. Cell Biol. 2001, 13, 363.
32. N. Shimada, K. Ishii, Y. Takeda, C. Coban, Y. Torii, S. Shinkai, S. Akira, K. Sakurai, Bioconjugate 2006, 17, 1136.
33. T. Kimura, K. Koumoto, K. Sakurai, S. Shinkai, Chem. Lett. 2000, 1242.
34. K. Koumoto, T. Kimura, H. Kobayashi, K. Sakurai, S. Shinkai, Chem. Lett. 2001, 908.
35. We showed that SPG-Am showed the exactly same CD spectral as that of unmodified SPG, and the ammonium cation enhances the complex stability. The complex of SPG-Am increased the cellular uptake in vitro and thus increased antisense effect (K. Koumoto, T. Kimura, M. Mizu, K. Sakurai, S. Shinkai, Chem. Commun. 2001, 1962;
36. T. Matsumoto, M. Numata, T. Anada, M. Mizu, K. Koumoto, K. Sakurai, T. Nagasaki, S. Shinkai, Biochim. Biophys. Acta 2004, 1670, 91).
37. S. Nakielny, G. Dreyfuss, Cell 1999, 99, 677.
38. K. Weis, Cell 2003, 112, 441.
39. N. W. Kim, M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, J. W. Shay, Science 1994, 266, 2011.
40. K. Tatematsu, J. Nakayama, M. Danbara, S. Shionoya, H. Sato, M. Omine, F. Ishikawa, Oncogene 1996, 13, 2265.
41. R. Karinaga, T. Anada, J. Minari, M. Mizu, K. Koumoto, J. Fukuda, K. Nakazawa, T. Hasegawa, M. Numata, S. Shinkai, K. Sakurai, Biomaterials 2006, 27, 1626.